SCHEMBL6150174

SCHEMBL6150174

O=[C]OCc1ccc(F)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
ALOX15 P16050 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46
POLB P06746 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
ADAMTS4 O75173 1/20 0.40
MMP2 P08253 1/20 0.40
MMP13 P45452 1/20 0.40
MMP14 P50281 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
MAPT P10636 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96252 0.81 IDO1 (0.58) SMN1; SMN2IDO1AGXTKDM4E
SCHEMBL47974 0.81 IDO1 (0.58) L3MBTL1HTTMAPTTDP1CYP1A2
SCHEMBL5535584 0.77 NR4A2 (0.38) L3MBTL1POLBRAB9AADAMTS4MMP2
SCHEMBL2091848 0.76 MRGPRX4 (0.43) CYP3A4CYP2C9
SCHEMBL7527722 0.76 ALDH1A1 (0.42) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10
SCHEMBL1520757 0.76 IDO1 (0.66) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10
SCHEMBL17071869 0.76 L3MBTL1 (0.47) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10
SCHEMBL2876824 0.75 L3MBTL1 (0.60) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10
Hydrochloric Acid SCHEMBL1715472 0.74 IDO1 (0.67) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10
SCHEMBL2876829 0.74 L3MBTL1 (0.58) ALDH1A1L3MBTL1ALOX15NPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177168-A4 CASPASE INHIBITORS AND THE USE THEREOF CYTOVIA INC (US) 2003-06-25 EP claimed
JP-2002541237-A 2002-12-03 JP claimed
EP-1177168-A1 CASPASE INHIBITORS AND THE USE THEREOF Cytovia, Inc. (US) 2002-02-06 EP claimed
WO-2000061542-A1 CASPASE INHIBITORS AND THE USE THEREOF CYTOVIA, INC. (US) 2000-10-19 WO claimed
EP-1494700-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS Cytovia, Inc. (US) 2005-01-12 EP disclosed
WO-2004002401-A2 CASPASE INHIBITORS FOR THE TREATMENT OF DISEASES AND CONDITIONS CAUSED BY EXPOSURE TO RADIONUCLIDES, BIOLOGICAL AGENTS, OR CHEMICAL AGENTS CYTOVIA, INC. (US) 2004-01-08 WO disclosed
EP-1177168-A4 CASPASE INHIBITORS AND THE USE THEREOF CYTOVIA INC (US) 2003-06-25 EP disclosed
EP-1177168-A1 CASPASE INHIBITORS AND THE USE THEREOF Cytovia, Inc. (US) 2002-02-06 EP disclosed
WO-2000061542-A1 CASPASE INHIBITORS AND THE USE THEREOF CYTOVIA, INC. (US) 2000-10-19 WO disclosed